Angiotensin II regulates oxygen consumption

被引:43
作者
Cassis, L [1 ]
Helton, M [1 ]
English, V [1 ]
Burke, G [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
关键词
body weight; energy expenditure;
D O I
10.1152/ajpregu.00261.2001
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Previous studies demonstrated that angiotensin II (ANG II) decreases body weight. This study examined whether ANG II regulates body weight through energy expenditure. Acute ANG II administration decreased oxygen consumption. To determine whether this effect was maintained, rats were infused with ANG II or saline for 14 days. Oxygen consumption was transiently decreased on day 1 of ANG II infusion; however, body weight and food intake were reduced for 14 days. In pair-feeding studies, reductions in food intake accounted for 63% of the effect of ANG II on body weight but did not influence systolic pressure, water intake, or oxygen consumption. With 28 days of ANG II infusion, differences in body weight between ANG II and control rats were of greater magnitude. An initial decrease in oxygen consumption was followed by a rebound increase. Coadministration of losartan prevented the effect of ANG II on body weight, food intake, blood pressure, and water intake. However, losartan only partially prevented ANG II reductions in oxygen consumption. These results demonstrate that ANG II transiently decreases oxygen consumption through mechanisms unrelated to food intake. With chronic ANG II exposure, energy expenditure may contribute to sustained reductions in body weight.
引用
收藏
页码:R445 / R453
页数:9
相关论文
共 26 条
[1]   Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells [J].
Aubert, J ;
Darimont, C ;
Safonova, I ;
Ailhaud, G ;
Negrel, R .
BIOCHEMICAL JOURNAL, 1997, 328 :701-706
[2]   Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism [J].
Brink, M ;
Wellen, J ;
Delafontaine, P .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2509-2516
[3]   CELLULAR-LOCALIZATION OF ANGIOTENSINOGEN GENE-EXPRESSION IN BROWN ADIPOSE-TISSUE AND MESENTERY - QUANTIFICATION OF MESSENGER-RIBONUCLEIC-ACID ABUNDANCE USING HYBRIDIZATION INSITU [J].
CAMPBELL, DJ ;
HABENER, JF .
ENDOCRINOLOGY, 1987, 121 (05) :1616-1626
[4]  
Cassis L A, 1991, J Neural Transm Suppl, V34, P129
[5]   Mechanisms contributing to angiotensin II regulation of body weight [J].
Cassis, LA ;
Marshall, DE ;
Fettinger, MJ ;
Rosenbluth, B ;
Lodder, RA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (05) :E867-E876
[6]  
Cassis LA, 1996, ADV EXP MED BIOL, V396, P39
[7]   LOCATION AND REGULATION OF RAT ANGIOTENSINOGEN MESSENGER-RNA [J].
CASSIS, LA ;
SAYE, J ;
PEACH, MJ .
HYPERTENSION, 1988, 11 (06) :591-596
[8]   LOCALIZATION OF ANGIOTENSINOGEN MESSENGER-RNA IN RAT AORTA [J].
CASSIS, LA ;
LYNCH, KR ;
PEACH, MJ .
CIRCULATION RESEARCH, 1988, 62 (06) :1259-1262
[9]   VASCULAR AND ENDOCRINE CONTROL OF MUSCLE METABOLISM [J].
CLARK, MG ;
COLQUHOUN, EQ ;
RATTIGAN, S ;
DORA, KA ;
ELDERSHAW, TPD ;
HALL, JL ;
YE, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05) :E797-E812
[10]   DEVELOPMENTAL ASPECTS OF THE ADIPOSE-TISSUE RENIN-ANGIOTENSIN SYSTEM - THERAPEUTIC IMPLICATIONS [J].
CRANDALL, DL ;
HERZLINGER, HE ;
SAUNDERS, BD ;
KRAL, JG .
DRUG DEVELOPMENT RESEARCH, 1994, 32 (02) :117-125